Sumatriptan and Etoposide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Etoposide (etoposide). Common drug interactions include neutropenia among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Etoposide. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Sumatriptan?
Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.
What is Etoposide?
Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.
29 people who take Sumatriptan and Etoposide together, and have interactions are studied.

What are the common drug interactions of Sumatriptan and Etoposide, by gender? *:
female:
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Blood alkaline phosphatase increased
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Infusion related reaction
- Lymphocyte count decreased
- Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
- Abdominal distension
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Abdominal pain
- Nausea (feeling of having an urge to vomit)
- Pancreatitis acute (sudden inflammation of pancreas)
- Vomiting
What are the common drug interactions of Sumatriptan and Etoposide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
- Stomatitis (inflammation of mucous membrane of mouth)
20-29:
n/a
30-39:
- Febrile neutropenia (fever with reduced white blood cells)
- Abdominal pain
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Atrioventricular block second degree (heart block second degree)
- Nausea (feeling of having an urge to vomit)
- Nodal arrhythmia (an irregular heart beat originating from within the atrioventricular node)
- Pancreatitis acute (sudden inflammation of pancreas)
- Sinus bradycardia (an unusually slow heartbeat due to heart disease)
- Vomiting
40-49:
- Febrile neutropenia (fever with reduced white blood cells)
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
50-59:
n/a
60+:
- Death
- Abdominal pain
- Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
- Abdominal distension
- Peripheral swelling
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Ascites (accumulation of fluid in the abdominal cavity)
- Oedema (fluid collection in tissue)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Blood alkaline phosphatase increased
What are the existing conditions these people have? *
- Pain: 16 people, 55.17%
- Constipation: 13 people, 44.83%
- Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 11 people, 37.93%
- Lung Cancer Metastatic (lung cancer spreads to other parts): 6 people, 20.69%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 17.24%
- Nausea And Vomiting: 4 people, 13.79%
- Nausea (feeling of having an urge to vomit): 4 people, 13.79%
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 4 people, 13.79%
- Dyspnea (difficult or laboured breathing): 4 people, 13.79%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 13.79%
* Approximation only. Some reports may have incomplete information.
Do you take Sumatriptan and Etoposide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sumatriptan (18,159 reports)
- Etoposide (77,815 reports)
Browse all drug interactions of Sumatriptan and Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sumatriptan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sumatriptan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Etoposide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sumatriptan succinate and etoposide (the active ingredients of Sumatriptan and Etoposide, respectively), and Sumatriptan and Etoposide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diverticulitis in Levothroid, how severe and when it was recovered? - now
- Could Doxazosin Mesylate cause Anuria? - 2 seconds ago
- Could Q10 cause Hyperkalemia? - 6 seconds ago
- Neuralgia and drugs of ingredients of ribavirin - 8 seconds ago
- Rashes and drugs of ingredients of cobalamin - 16 seconds ago
- Drug interactions of Vitamin C and Stelara - 17 seconds ago
- Sepsis Syndrome and drugs of ingredients of zolpidem tartrate - 19 seconds ago
- Ribavirin and Postherpetic Neuralgia for Men aged 50-59 - 28 seconds ago
- Ribavirin and Nerve Pain for Men aged 50-59 - 28 seconds ago
- Ribavirin and Neuralgia for Men aged 50-59 - 29 seconds ago